111 Inc
YI6.760USD
-0.160-2.31%
取引時間 （ET）15分遅れの株価
342.56M時価総額
損失額直近12ヶ月PER
詳細情報 111 Inc 企業名
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.
企業情報
企業コードYI
会社名111 Inc
上場日Sep 12, 2018
最高経営責任者「CEO」Mr. Junling Liu
従業員数1238
証券種類Depository Receipt
決算期末Sep 12
本社所在地3-4/F, No.295 Zuchongzhi Road
都市SHANGHAI
証券取引所NASDAQ Global Market Consolidated
国China
郵便番号201203
電話番号862120536666
ウェブサイトhttp://corporate.111.com.cn/
企業コードYI
上場日Sep 12, 2018
最高経営責任者「CEO」Mr. Junling Liu
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Junling Liu
Mr. Junling Liu
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Gang Yu, Ph.D.
Dr. Gang Yu, Ph.D.
Executive Co-Chairman of the Board, Co-Founder
Executive Co-Chairman of the Board, Co-Founder
--
--
Mr. Yang (Luke) Chen
Mr. Yang (Luke) Chen
Director
Director
--
--
Mr. Jun Luo
Mr. Jun Luo
Independent Director
Independent Director
--
--
Mr. Jian (David) Sun
Mr. Jian (David) Sun
Independent Director
Independent Director
--
--
Mr. Nee Chuan Teo, CPA
Mr. Nee Chuan Teo, CPA
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Junling Liu
Mr. Junling Liu
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Gang Yu, Ph.D.
Dr. Gang Yu, Ph.D.
Executive Co-Chairman of the Board, Co-Founder
Executive Co-Chairman of the Board, Co-Founder
--
--
Mr. Yang (Luke) Chen
Mr. Yang (Luke) Chen
Director
Director
--
--
Mr. Jun Luo
Mr. Jun Luo
Independent Director
Independent Director
--
--
Mr. Jian (David) Sun
Mr. Jian (David) Sun
Independent Director
Independent Director
--
--
Mr. Nee Chuan Teo, CPA
Mr. Nee Chuan Teo, CPA
Independent Director
Independent Director
--
--
収益内訳
通貨: CNY更新時刻: Sun, Jul 6
通貨: CNY更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
事業別CNY
会社名
収益
比率
Product Revenues
3.51B
99.44%
Service Revenues
19.70M
0.56%
データなし
事業別
地域別
事業別CNY
会社名
収益
比率
Product Revenues
3.51B
99.44%
Service Revenues
19.70M
0.56%
株主
更新時刻: Sat, May 17
更新時刻: Sat, May 17
株主統計
種類
株主統計
株主統計
比率
ClearVue Partners
15.64%
First Pharmacia International
8.57%
6 Dimensions Capital Ltd.
7.15%
Zall Capital Ltd
2.82%
Tongyi Investment Holding Ltd
2.13%
Other
63.69%
株主統計
株主統計
比率
ClearVue Partners
15.64%
First Pharmacia International
8.57%
6 Dimensions Capital Ltd.
7.15%
Zall Capital Ltd
2.82%
Tongyi Investment Holding Ltd
2.13%
Other
63.69%
種類
株主統計
比率
Corporation
15.84%
Private Equity
15.64%
Venture Capital
7.15%
Investment Advisor
0.32%
Hedge Fund
0.25%
Investment Advisor/Hedge Fund
0.22%
Research Firm
0.11%
Other
60.47%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
48
2.00M
39.53%
-385.56K
2025Q1
49
2.00M
39.53%
-387.91K
2024Q4
51
2.26M
44.72%
+133.67K
2024Q3
43
1.99M
39.36%
-280.22K
2024Q2
45
2.17M
42.88%
-87.92K
2024Q1
52
2.15M
42.65%
-125.45K
2023Q4
54
2.16M
44.89%
-28.04K
2023Q3
57
2.15M
44.81%
-47.43K
2023Q2
64
2.05M
43.37%
+895.26K
2023Q1
77
2.20M
46.58%
+971.22K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
ClearVue Partners
792.41K
15.64%
--
--
Feb 27, 2024
First Pharmacia International
434.53K
8.57%
--
--
Mar 31, 2025
6 Dimensions Capital Ltd.
362.30K
7.15%
--
--
Feb 27, 2024
Zall Capital Ltd
143.12K
2.82%
--
--
Feb 27, 2024
Tongyi Investment Holding Ltd
107.78K
2.13%
--
--
Feb 27, 2024
Allied China Investment Ltd
94.97K
1.87%
--
--
Feb 27, 2024
J.P. Morgan Trust Company of Delaware
22.17K
0.44%
--
--
Feb 27, 2024
Renaissance Technologies LLC
12.81K
0.25%
-531.00
-3.98%
Mar 31, 2025
Connor, Clark & Lunn Investment Management Ltd.
11.34K
0.22%
+11.34K
--
Mar 31, 2025
Deuterium Capital Management, LLC
10.00K
0.2%
+10.00K
--
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Aug 2
更新時刻: Sat, Aug 2
銘柄名
比率
SPDR Portfolio Emerging Markets ETF
0%
SPDR S&P Emerging Asia Pacific ETF
0%
Invesco Golden Dragon China ETF
0%
SPDR S&P Emerging Markets Small Cap ETF
0%
SPDR Portfolio Emerging Markets ETF
比率0%
SPDR S&P Emerging Asia Pacific ETF
比率0%
Invesco Golden Dragon China ETF
比率0%
SPDR S&P Emerging Markets Small Cap ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Jan 03, 2025
Merger
10<1
Jan 03, 2025
Merger
10<1
Jan 03, 2025
Merger
10<1
Jan 03, 2025
Merger
10<1
日付
種類
比率
Jan 03, 2025
Merger
10<1
Jan 03, 2025
Merger
10<1
Jan 03, 2025
Merger
10<1
Jan 03, 2025
Merger
10<1
